Outperforming Cancer: Stacking Evidence-Based Strategies on Top of Standard Care

<p>When Marybeth Gilliam was diagnosed with metastatic breast cancer, she did what her years as a healthcare researcher had trained her to do: she went looking for the evidence. What she found was a gap between a growing body of peer-reviewed research pointing to strategies that can improve outcomes, and the fact that most of it never reached patients because it hadn&#39;t yet become standard of care.In this episode of Patient From Hell, host Samira Daswani sits down with Marybeth, founder of Outperform Cancer, to talk about how she is working to close that gap. She translates overlooked, peer-reviewed findings into steps patients can actually take, always paired with standard treatment rather than in place of it. Exercise, nutrition, and sleep are part of it, and so is asking sharper questions about biomarker testing, weighing well-supported off-label options, and refusing to take no for an answer when the data is strong.She shares her own story, the research that reshaped her thinking, and a practical case for taking an active role in your care when the first treatment decisions matter most.In this episode:Why she founded Outperform Cancer to close the gap between research and the clinicHow she pairs evidence-based strategies with standard treatment, not instead of itBiomarker testing and advocating for off-label options backed by solid trials (PATINA, MA.32)What being your own advocate actually looks like in the exam roomThis podcast is for general informational purposes only and does not constitute medical advice. The opinions of the speakers are their own.<br></p><p><br></p><p>CHAPTERS</p><p>00:00 The overlooked risk factor after childbirth</p><p>00:39 Meet Marybeth Gilliam</p><p>00:53 Why she founded Outperform Cancer</p><p>02:15 The cancer care information gap</p><p>02:20 The exercise discovery that changed everything</p><p>04:14 Her metastatic breast cancer diagnosis</p><p>06:11 Looking back at her 2007 Stage 0 diagnosis</p><p>07:16 Postpartum breast cancer and recurrence risk10:36 Building an anti-cancer strategy</p><p>13:58 From metastatic diagnosis to NED</p><p>15:48 Exercise, sleep, nutrition, and lifestyle changes18:24 Creating an anti-cancer environment20:03 The PATINA trial explained</p><p>23:24 Accessing promising therapies before standard of care</p><p>25:46 How patients can advocate for themselves</p><p>27:51 The 15-year research-to-practice gap</p><p>28:45 Precision medicine and biomarker testing</p><p>30:42 The ATM gene and metformin research</p><p>32:08 Stacking interventions: what does the evidence say?</p><p>33:08 Balancing risk, reward, and patient choice</p><p>35:24 Lessons from cancer innovators and patient-led research</p><p>37:00 Final thoughts and takeaways</p><p><br></p><p>Follow Patient From Hell for more conversations on cancer, survivorship, patient advocacy, research breakthroughs, and navigating healthcare with confidence.</p><p><br></p><p>Understanding postpartum breast cancer risks is critical. Learn why a diagnosis within 10 years of childbirth changes prognosis.</p><p><br></p><p>Many patients do not realize that postpartum breast cancer is defined as a diagnosis within 10 years of having children. This video explains the medical reasoning behind why these patients face a significantly higher likelihood of recurrence compared to other groups. We specifically look at the data showing that even stage one patients are three times more prone to metastasis during this specific window.</p>